ArticleJournal of managed care & specialty pharmacy2026

Health care use and costs associated with clinically impactful immune-related adverse events during immune checkpoint inhibitor therapy for non-small cell lung cancer.

Olajumoke A Olateju et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.